Where does Spogen Biotech, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Spogen Biotech, Inc. ranks #9,626 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Spogen Biotech, Inc. hold?

Spogen Biotech, Inc. holds 33 US utility patents granted between 2016 and 2025, spanning 26 technology areas.

What is Spogen Biotech, Inc.'s Innovation Score?

Spogen Biotech, Inc. has an Innovation Score of 48.1 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Spogen Biotech, Inc.'s patent grant rate increasing or decreasing?

Spogen Biotech, Inc.'s recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Spogen Biotech, Inc.'s patents?

Spogen Biotech, Inc.'s patents average 30.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Spogen Biotech, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Spogen Biotech, Inc.

Q: What technology areas does Spogen Biotech, Inc. focus on?

Spogen Biotech, Inc.'s top technology area is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators) with 28 patents, ranking #51 of 1,216 assignees active in that subclass. Grants appear in 26 CPC subclasses total.

USPTO PatentsView assignee record - 33 granted patents across 26 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Spogen ranks #9,626 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 26 technology areas.

#9,626
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.1/100): 30.6
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9626 · US Corporation #9,626 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,626/49,997
PHOTO-FINISH Safran Cabin
CPC-FOCUS A01N · 26 areas
INNOV-PAR 48.1/100
CLAIMS-DENSE 30.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Safran Cabin Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Spogen’s 48.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.2 pts (25%) Velocity 2.9 pts (6%) Breadth 18.0 pts (37%) Claim depth 15.0 pts (31%)

Qualcomm Incorporated · highest

85
Buckingham Manufactu… · near

48
Toray Engineering · near

48
Carl Zeiss Spectrosc… · near

48
Oakley · near

48
Spogen Biotech · this assignee

48
3D Lighting… · lowest

7

What this shows Spogen's Innovation Score is 48.1/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Spogen?

Each dot is one of Spogen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Spogen’s own 30.6 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Spogen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Spogen's grants concentrate

Spogen Biotech, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 84.8% of grants classified under A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2016. By volume, Spogen sits between Shaw Industries Group, Inc. and Safran Cabin Inc..

Spogen's three-year grant acceleration

Spogen Biotech, Inc. shows 7 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Shaw Industries G…

33
Shibaura

33
SLT

33
Softbank Robotics…

33
STM Management Pty

33
Sunstar Engineeri…

33
Syneron Medical

33
Safran Cabin

33
Spogen Biotech ◀

33

What this shows Spogen holds 33 patents at rank #9,614, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Spogen

By rank, the assignees closest to #9,614 in granted patent volume.

Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)

Other assignees with the most granted patents in Spogen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Spogen, neither rank-band nor same-CPC leaders (those blocks stay above). In A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…), Spogen ranks #51 of 1,216 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Oakley, Inc. 48 Carl Zeiss Spectroscopy GmbH 48 Buckingham Manufacturing Company, Inc. 48 Toray Engineering Co., Ltd. 48

Spogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Spogen Biotech, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	3.0%
2017	3	9.1%
2018	1	3.0%
2019	3	9.1%
2020	6	18.2%
2021	7	21.2%
2022	2	6.1%
2024	5	15.2%
2025partial year	5	15.2%

Which technologies does Spogen Biotech, Inc. patent most?

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 28

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 25

C07K - Peptides 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

C12Y - Enzymes 16

Y02A - Technologies FOR Adaptation TO Climate Change 8

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 8

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 8

A23K - Fodder 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 5

E21B - Earth OR Rock DRILLING; Obtaining OIL, GAS, Water, Soluble OR Meltable Materials OR A Slurry OF Minerals From Wells 5

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 5

C02F - Treatment OF Water, Waste Water, Sewage, OR Sludge 5

A01C - PLANTING; SOWING; Fertilising 4

A01M - Catching, Trapping OR Scaring OF Animals ; Apparatus FOR THE Destruction OF Noxious Animals OR Noxious Plants 4

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Spogen Biotech, Inc.'s patent record in context - here's where to go next.

Spogen Biotech, Inc.'s lead technology class is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators), 84.8% of its portfolio - see every assignee active in that class. Explore A01N
Ranked #9,626 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Spogen Biotech, Inc. against Shaw Industries Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.